These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3107646)

  • 1. Interferon-gamma: actions and importance.
    Wardle EN
    Br J Hosp Med; 1987 May; 37(5):446-8. PubMed ID: 3107646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo generation, enhancement and recruitment of host cellular immune responses against tumor: influence of MHC antigen expression on clones of tumor cell variants.
    Fernández-Cruz E; Pérez M; Zabay JM; Garrido F
    Prog Clin Biol Res; 1987; 244():115-25. PubMed ID: 2958867
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological activity of gamma interferon.
    Dianzani F; Antonelli G; Capobianchi MR
    Ann Ist Super Sanita; 1990; 26(3-4):255-61. PubMed ID: 2128676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function.
    Fischer HG; Frosch S; Reske K; Reske-Kunz AB
    J Immunol; 1988 Dec; 141(11):3882-8. PubMed ID: 3141506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of morphine on cell-mediated immune responses of human lymphocytes against allogeneic malignant cells.
    Fuggetta MP; Di Francesco P; Falchetti R; Cottarelli A; Rossi L; Tricarico M; Lanzilli G
    J Exp Clin Cancer Res; 2005 Jun; 24(2):255-63. PubMed ID: 16110759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor.
    Falk LA; Wahl LM; Vogel SN
    J Immunol; 1988 Apr; 140(8):2652-60. PubMed ID: 3128601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromelain activates murine macrophages and natural killer cells in vitro.
    Engwerda CR; Andrew D; Murphy M; Mynott TL
    Cell Immunol; 2001 May; 210(1):5-10. PubMed ID: 11485347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity in nutritional deficiency.
    McMurray DN
    Prog Food Nutr Sci; 1984; 8(3-4):193-228. PubMed ID: 6396715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant interleukin 12 enhances cellular immune responses to vaccination only after a period of suppression.
    Kurzawa H; Wysocka M; Aruga E; Chang AE; Trinchieri G; Lee WM
    Cancer Res; 1998 Feb; 58(3):491-9. PubMed ID: 9458095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A T cell-independent mechanism of macrophage activation by interferon-gamma.
    Bancroft GJ; Schreiber RD; Bosma GC; Bosma MJ; Unanue ER
    J Immunol; 1987 Aug; 139(4):1104-7. PubMed ID: 3112223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bactericidal activity of cells of the immune system].
    Wargnier A; Lagrange PH
    Pathol Biol (Paris); 1993 Nov; 41(9):887-96. PubMed ID: 8121721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults.
    Vandepapelière P; Rehermann B; Koutsoukos M; Moris P; Garçon N; Wettendorff M; Leroux-Roels G
    Vaccine; 2005 Apr; 23(20):2591-601. PubMed ID: 15780441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and function of human interferon-gamma.
    Vilcek J; Kelker HC; Le J; Yip YK
    Symp Fundam Cancer Res; 1984; 37():299-313. PubMed ID: 6441990
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-cell immunity against the parental tumor.
    Dan Q; Sanchez R; Delgado C; Wepsic HT; Morgan K; Chen Y; Jeffes EW; Lowell CA; Morgan TR; Jadus MR
    Mol Ther; 2001 Nov; 4(5):427-37. PubMed ID: 11708879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
    J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between cytokines and 8-mercaptoguanosine in humoral immunity: synergy with interferon.
    Goodman MG
    J Immunol; 1987 Jul; 139(1):142-6. PubMed ID: 3108396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.